Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy
Evasion of apoptosis is a hallmark of cancer, attributed in part to overexpression of the anti-apoptotic protein B-cell lymphoma 2 (Bcl-2). In a variety of cancer types, including lymphoma, Bcl-2 is overexpressed. Therapeutic targeting of Bcl-2 has demonstrated efficacy in the clinic and is the subj...
Tallennettuna:
| Päätekijät: | , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2023-04-01
|
| Sarja: | Acta Pharmaceutica Sinica B |
| Aiheet: | |
| Linkit: | http://www.sciencedirect.com/science/article/pii/S2211383522003239 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|